Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesMRIMRI-based model shows changes over time in multiple myeloma patientsWhole-body MRI could serve as a scalable biomarker for risk stratification in multiple myeloma patients.UltrasoundThyroid nodule classification systems provide diagnostic equityInterventionalY-90 TARE rises to top in treatments for liver transplant patientsUltrasoundUltrasound MinnieCast, Episode 16: How to create a sonography associationISeConsult systems may benefit radiology-provider communication